At the TP ICAP Forum, SideTrade faced three questions, CytoDyn unveiled Phase 2 NASH clinical trial results, and FORUM DEV CO23 highlighted agencies' contributions to business implantation and expansion in 2022. Explore these topics and learn about the latest developments in finance, cryptocurrency, and business development. Stay informed with our comprehensive coverage.